Immune Biosolutions, DIEX Recherche, Université de Sherbrooke and Keyrus Life Science Partner up to Fight COVID-19


Sherbrooke, April 20, 2020 – Immune Biosolutions, Diex Research, Keyrus Life Science and the Faculty of Medicine and Health Sciences of the Université de Sherbrooke (FMSS) are joining forces to discover and develop innovative solutions against the SARS-CoV-2 virus. Under the leadership of Immune Biosolutions, a biotechnology company from the Université de Sherbrooke ecosystem, a team came together in collaboration with several research groups and more than a dozen private and public organizations to identify therapeutic antibodies from blood samples from recovered patients. These efforts could lead to the development of coronavirus immunotherapy as well as better diagnostic tools. This discovery program is part of a series of initiatives to counter the COVID-19 pandemic. Read More

Back to posts